SEC Form 4 · accession 0001104659-15-072543
Radius Health, Inc. · RDUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Hattersley
Officer — Chief Scientific Officer
Period of report
Oct 21, 2015
Accepted (ET)
Oct 23, 2015 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428522
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 21, 2015 | M | 1,501 | $3.42 | A | 1,501 | D | |
| Common StockF2 | Oct 21, 2015 | S | 1,501 | $65.36 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.42 | Oct 21, 2015 | M | 1,501 | D | Dec 31, 2009 | Feb 15, 2016 | Common Stock | 1,501 | 874 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2015.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $65.00 to $65.97. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.